4.3 Letter

COVID-19 vaccine acceptance among patients with glomerulonephritis

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

Simon Galmiche et al.

Summary: This article systematically reviews the immunogenicity, efficacy, and effectiveness of COVID-19 vaccines in immunocompromised populations. The results highlight the risk of low immunogenicity in solid organ transplant recipients and patients with hematological malignancy. Enhanced vaccine regimens may be necessary despite the lack of vaccine effectiveness data.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Editorial Material Urology & Nephrology

De novo and relapsing glomerulonephritis after COVID-19 vaccination: how much do we know?

Anthony T. P. Chan et al.

NEPHROLOGY (2022)

Article Public, Environmental & Occupational Health

Measuring health literacy in Asia: Validation of the HLS-EU-Q47 survey tool in six Asian countries

Tuyen V. Duong et al.

JOURNAL OF EPIDEMIOLOGY (2017)

Article Immunology

Vaccine hesitancy: Definition, scope and determinants

Noni E. MacDonald

VACCINE (2015)